September 22, 2023
RegMed Investors’ (RMi) pre-open: look for “some” buy points
September 21, 2023
RegMed Investors’ (RMi) pre-open: Wherefore art thou?
September 20, 2023
RegMed Investors’ (RMi) pre-open: brace
September 19, 2023
RegMed Investors’ (RMi) pre-open: Sector share pricing is disconnected from everything
September 18, 2023
RegMed Investors’ (RMi) pre-open: who has a share pricing compass or even a barometer?
September 15, 2023
RegMed Investors’ (RMi) pre-open: understanding perception
September 14, 2023
RegMed Investors’ (RMi) pre-open: the known unknowns
September 13, 2023
RegMed Investors’ (RMi) pre-open: try catching fog in a glass
September 12, 2023
RegMed Investors’ (RMi) pre-open: show me the money
September 11, 2023
RegMed Investors’ (RMi) pre-open: The September Effect
September 8, 2023
RegMed Investors’ (RMi) pre-open: reverse the sector’s downer curse
September 7, 2023
RegMed Investors’ (RMi) pre-open: Hope is not a good investment strategy
September 6, 2023
RegMed Investors’ (RMi) pre-open: risk gets riskier
September 5, 2023
RegMed Investors’ (RMi) pre-open: a challenging September ahead?
September 1, 2023
RegMed Investors’ (RMi) pre-open: patterns exist and then they don’t
August 31, 2023
RegMed Investors’ (RMi) pre-open: gains and losses
August 30, 2023
RegMed Investors’ (RMi) pre-open: the Icarus metaphor
August 29, 2023
RegMed Investors’ (RMi) pre-open: timing
August 28, 2023
RegMed Investors’ (RMi) pre-open: musical chairs
August 25, 2023
RegMed Investors’ (RMi) pre-open: share pricing versus Jerome
August 24, 2023
RegMed Investors’ (RMi) pre-open: anticipation versus expectation
August 23, 2023
RegMed Investors’ (RMi) pre-open: the outlook for cell and gene therapy equities remains challenging
August 22, 2023
RegMed Investors’ (RMi) pre-open: risk involves uncertainty
August 21, 2023
RegMed Investors’ (RMi) pre-open: it’s time to dive into the sector’s share pricing
August 18, 2023
RegMed Investors’ (RMi) pre-open: a set-up for ending the week on a weak note
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2023 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.